Eli Lilly and Company nelle notizie
Sviluppo di farmaci per le esigenze
Tamtam ha trovato 20 articoli recenti su Eli Lilly and Company.
- Transcript: Eli Lilly Q2 2026 Earnings Conference Call
- If You Invested $1000 in Eli Lilly a Decade Ago, This is How Much It'd Be Worth Now
- Eli Lilly (LLY) Has a Powerful Growth Flywheel Beyond Its GLP-1 Success
- Eli Lilly and the LA Dodgers: A tale of 2 dynasties
- Eli Lilly sued over stomach problems patient ties to Mounjaro and Trulicity
- Eli Lilly Quietly Expands Its Alzheimer’s Pipeline With New Early-Stage Trial
- Eli Lilly: Buy The GLP-1 Growth Premium
- Eli Lilly: Impressive Growth, Questionable Valuation (NYSE:LLY)
- This Small-Cap Stock Announced a Deal With Eli Lilly. Then Its Shares Doubled
- Eli Lilly and vs. Novo Nordisk A/S: Which Healthcare Stock Is a Better Buy in 2026?
- Eli Lilly Has Been a Growth Beast, but This Is the Riskiest Part About Its Stock
- Eli Lilly Stock (LLY) Gains on Regulatory Win for Experimental Cancer Drug
- Eli Lilly vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
- Lilly doubles down on Gate alliance to unlock new drug class with another $870M+ in biobucks
- Eli Lilly Just Announced Something Big. Here’s What It Means for Investors.
- Lilly signals move into aesthetics, looking to add products for body, skin and hair
- Prediction: Eli Lilly Could Be the Next $2 Trillion Drugmaker
- Katwijk approves permits for $3 billion Eli Lilly pharmaceutical plant
- Lilly bypasses Australian pharmacies with DTC model
- How Eli Lilly Just Extended Its Lead in the Weight-Loss Drug Market
Articoli raccolti da Tamtam e conservati quando riguardano l'azienda, dal più recente. Ognuno rimanda alla sua fonte.
Vendi ad aziende come Eli Lilly and Company?
Tamtam trova le aziende in linea con il tuo cliente ideale, analizza ogni account e ti dice chi contattare e quando.
Trova aziende simili